chrisvoncsefalvay/vaers-outcomes huggingface dataset:
heart attack; he ended up having a triple bypass to clear the blockage found.; extremely lethargic; chest pains; This is a spontaneous report received from a Non-contactable consumer(patient). An adult male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular on 20May2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 for covid-19 immunisation and tested COVID positive a few weeks after receiving his first vaccine. Once all virus symptoms were gone, he was advised by the clinic to go ahead and get his second shot (approximately 1 week after virus symptoms cleared). The vaccine was given on 20May2021 and within several days, he was extremely lethargic and experiencing chest pains. During a visit to local urgent care he was told he had had a heart attack. Following an echocardiogram, he ended up having a triple bypass to clear the blockage found. He did have some family history of heart disease but was unaware of any issues with his own health and had not experienced any symptoms prior to this incident. Date of start of reaction/event was 23May2021. The adverse events result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. It was reported no hospitalization prolonged. The outcome of event extremely lethargic was unknown, of the other events was recovering.  Information about lot/batch number has been requested.
This was my third vaccine/booster. It resulted in a metallic taste in my mouth, nerve pain on my face and torso and splitting headaches, off and on, for about 10 days.  2nd vaccine (Pfizer): Rash on my torso, headaches. Asked to remain for observation for 30 min. 1st vaccine (Pfizer): Hives on neck within about 45 mins. Splitting headaches, itchy rash for about 10 days.
30APR91 t104.2, swelling of lt arm, rash, pain in joints w/redness, swelling, tenderness & hyporesponsive episode;
4/29 morning after the moderna Covid 2nd injection my dad called me to say my mom was extremely weak and could not stand. When I arrived she was laying in the floor very nauseous and could not stand on her own. She had crawled to bathroom and then just laid on floor in hallway outside of bathroom. I called 911 to check her vitals as she wasn?t responding much but she was conscious. EMTs got her sitting in a chair and checked BP 190/90 and pulse and pulse ox was 94. She dry vomited once and EMTs got her in her bed and eventually she became a bit more alert as was able to sip water and tea and a few bites of toast. Just in and out falling asleep. As of 2:40 pm on 4/29 just sleeping.
It was the end of the day and the patients date of birth was overlooked.  The patient was monitored for 15 minutes following the vaccine administration and no adverse events occurred.
APPROXIMATELY 4 MINUTES AFTER RECEIVING H1N1 VACCINATION. PATIENT TALKING TO PEER. PATIENT WAS SITTING IN CHAIR THEN SLUMPED OVER WITH EYES ROLLED BACK,ARMS AND LEGS BECAME STIFF WITH FISTS CLENCED AND TURNED INWARD. THIS POSTURE LASTED APPROXIMATELY 20-30SECONDS. PATIENT BECOME LUCID AND SAID "OK". AUNT AT PATIENT'S SIDE, TALKING TO PATIENT. PATIENT WAS SITTING THEN BEGAN HAVING EPISODE OF QUESTIONABLE SEIZURE-LIKE ACTIVITY FOR 30-45 SECONDS. BP.72/? HEART RATE64 RESPIRATORY RATE 20. EMS(911) CALLED VITAL SIGN RECHECK BP.92/58 HR.64 RR20, PATIENT ALERT AND ORIENTED TO TIME, PLACE, AND PERSON, WITH STABLE VITAL SIGNS.PATIENT SLEEPY UPON EMS ARRIVAL FOR TRANSFER TO SELF REGIONAL HEALTHCARE SYSTEM - EMERGENCY ROOM
left sided hemiplegia, found down 4/20 @3:30pm, found to have left ICA territory stroke with M1 occlusion, outside of window for tPA and thrombectomy, underwent decompressive hemicraniectomy
Subsequently, the pt experienced an anaphylactic reaction. The pt sought unspecified medical attention.
Subsequent to receiving vax, the pt developed a large local reaction at the left thigh injection site that measured 2 X 3 inches. Further information is requested.
experienced migraine, double vision, and droopy eyelid when he took the 1st dose; experienced migraine, double vision, and droopy eyelid when he took the 1st dose; experienced migraine, double vision, and droopy eyelid when he took the 1st dose; This is a spontaneous report from Pfizer Sponsored Program. A contactable male consumer patient (reporting for herself). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE), dose 1 via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  It was reported that patient received first dose of Pfizer covid vaccine on 20Mar2021. The 2nd dose should be on 10Apr2021, but the patient rescheduled the 2nd dose because the patient experienced migraine, double vision, and droopy eyelid on unspecified date when patient took the 1st dose. The patient would like to know if what are the side effects of the vaccine before he will take the 2nd dose and would also like to know if he needs to take the 2nd dose or not. Provided the number. The patient refused to be transferred to PMI because he already spoke to them and receive no help. Outcome of the events unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 25-OCT-2017, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 lot number N011867 and expiration date of 08-NOV-2018 for prophylaxis (dose and route of administration were not reported). No adverse effects were reported. The vaccine was exposed to a temperature excursion of 9°C to 25°C with a time frame of 1 hour. There was no information regarding previous temperature excursion nor data logger involved. There was not product quality complaint involved. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1711USA007577: US-009507513-1712USA002496: US-009507513-1712USA002494.
At 6am I was awakened with chills, muscle aches.  I took a Tylenol and went back to bed sleeping another 4 hours after already sleeping for 8 hours. I spent the remainder of the day with fatigue and sometimes muscle aches. I took one more Tylenol and the symptoms subsided by 6 pm that day.
Body aches, chills, diarrhea, restlessness, headache. Lasted about 35 hours.
Pain in right arm - unable to lift above shoulder level. Weakness when holding an object heavier than a glass. Causes sleepless nights because of the pain.
Severe unbearable headaches and body aches .. unable to function and caused job loss and thousands in ED medical costs
Narrative: Hypertension lymphedema, htn chest pain started first dose Moderna and got worse each subsequent dose not certain related to vaccine
Localized erythema/induration; suspected cellulitis 2d. after vaccine administration. Rx'd PO Abx and f/u arranged.
24 y.o. patient at day 10 post smallpox vaccination.  Reports intermittent fever, up to 102 degrees, increased rash, increased pruritis, and malaise time 3 days.  On exam, prominent acneiform appearing rash with areas of confluence, especially around inoculation site.  Rash spares hands, feet, head and neck.  Reviewed with agency and physician after sending photos.  Assessment: Robust take in immunocompetent male.  Plan:  Benadryl prn, Tylenol prn, Prednisone taper.  S,M, will RTC in 3 days.  Sooner if problems.  (Information received from Doctor).
Patient fainted the day after receiving the shot. He was found on the ground and was not responsive at first but he came to after an hour.
Roughly 24 hours post second dose I developed a small red rash with moderate edema to my inner bicep area and across the front of my arm not near the injection site location. Swelling and redness intensified throughout the day growing larger and taking up the majority of my arm. Hot to the touch. Pain is tolerable. Swelling significant.
hard to lift arm; under the left arm started hurting; pain at injection site of left arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (hard to lift arm), VACCINATION SITE PAIN (pain at injection site of left arm) and MYALGIA (under the left arm started hurting) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site of left arm). On 17-Jun-2021, the patient experienced MOBILITY DECREASED (hard to lift arm) and MYALGIA (under the left arm started hurting). At the time of the report, MOBILITY DECREASED (hard to lift arm), VACCINATION SITE PAIN (pain at injection site of left arm) and MYALGIA (under the left arm started hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided Treatment medications were not provided by reporter   Reporter did not allow further contact
Onset of pruritis R lower back with onset of rash next day with development of clear pustules.   Patient seen by PCM  on Monday February 8th and diagnosed with Shingles and treated with antivirals with resolution of symptoms/rash
administered FLUZONE QUADRIVALENT MDV post excursion.; Initial information received on 24-May-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 10 months old male patient who was administered fluzone quadrivalent mdv post excursion. while receiving vaccine influenza quadrival a-b vaccine [Fluzone Quadrivalent].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 14-Apr-2022, the patient received a  dose of suspect influenza quadrival a-b vaccine lot UJ705AB via intramuscular route in the left thigh. (formulation: unknown, strength: standard,  and expiry date: 30-June-2022)   the patient was administered fluzone quadrivalent mdv post excursion. (poor quality product administered) following the administration of influenza quadrival a-b vaccine.  Action taken with quadrivalent influenza vaccine was not applicable.  At time of reporting, the outcome was Unknown for the event administered fluzone quadrivalent mdv post excursion.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
49 yo lady with history of menorrhagia and cerebral venous sinus thrombosis in 2015 following 2 weeks of oral contraceptive use presented with altered mental status on 10/24/21.  CT scans showed multiple CNS hemorrhages on the left with some degree of uncal herniation.   CT angiogram showed thrombosis of multiple cerebral venous sinuses. Patient was taken to the OR for left fronto-temporal-parietal craniectomy for decompression of the brain .   She was carefully started on a heparin drip post operatively and remains in the ICU intubated and sedated.  On questioning patient's family reports that she was on warfarin for 6 months in 2015 for the venous sinus thrombosis then taken off at the advice of hematology when imaging showed near complete resolution of the clots.  Hypercoagulable work up was negative.  Family reports patient was in good health until 10/23/21,  the day following her first Moderna vaccine,  when she developed fever and headache.  The following morning (10/24/21) she was found confused and unresponsive and was taken to the hospital.  Of note post operatively her platelet count dipped from a baseline of about 340,000 to about 200,000.  Heme was called and a heparin antibody test was sent and is pending.
I noticed on Day 3 after shot that my arm was increasingly red and tender with a hot red bump at the injection site. By day 7 the injection site had swelled to more than three times its size and became even more painful itchy and red. By Saturday the 9th day the size of the injection site had taken over the majority of the upper part of my arm. At that point I decided I needed urgent Care. I was seen by a doctor who said she had similar reactions but once she felt the heat coming from my arm she placed me on Doxycycline, Zyrtec, and Benadryl. After using the new medicines for 2 days the spot on my arm grew even more and became an irregular shape. Once I saw the irregular shape and continued swelling I made an appointment to see my regular family doctor. My doctor decided to put me on the antibiotic Keflex in addition to the Doxycycline, Zyrtec, and Benadryl. I am now at day 14 since the injection, I am continuing all Keflex, Doxycycline, Zyrtec, Benadryl, and I am still experiencing some discomfort and itching. My doctor gave me the option to use steroids but the swelling and redness has gone away so we are going to hold off for now. If symptoms persist we will seek blood tests.
CONSTANT DIZZINESS FOR DAYS NO MATTER WHAT EAT; SHAKING DURING OR BEFORE EATING; BLURRY VISION; SWEATING WHILE EATING; DIARRHOEA; NUMBNESS IN HANDS AND FINGERS; FATIGUE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced constant dizziness for days no matter what eat, shaking during or before eating, blurry vision, sweating while eating, diarrhoea, numbness in hands and fingers, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the constant dizziness for days no matter what eat, diarrhoea, shaking during or before eating, blurry vision, numbness in hands and fingers, sweating while eating and fatigue was not reported. This report was non-serious.
After vaccines dazed; quiet; poor eye control; decreased respirations, lethargic, no LOC.  Stimulated, 6L O2/min by mask, ->improved respirations, better eye contact, fed bottle.  Sent via ambulance to STCH ER.
Acute Pain of Right Shoulder (Adverse effect of diphtheria, tetanus, pertussis vaccine)  predniSONE (Deltasone) 20mg tablet, take 3 tabs daily for 3 days, then 1 tab for 3 days, then 1 tab every other day until gone. tiZANidine (Zanaflex) 4mg tablet, Take 1 tablet by mouth every 8 hours as needed for muscle spasms. Physical Therapy for 10 days No Outcome
COVID-19/ tested positive for Covid-19; loss of taste; loss of smell; loss of appetite; loss control of bladder; extreme weakness; Blood sugar decreased; Diarrhea; Vomiting; Nausea; fatigue/ tiredness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID-19/ tested positive for Covid-19) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Leg amputation. Concurrent medical conditions included Diabetes mellitus, Atrial fibrillation and Hypothyroidism. Concomitant products included INSULIN ASPART (NOVOLOG) and METFORMIN for Diabetes, LEVOTHYROXINE for Hypothyroidism, METHOTREXATE, VERAPAMIL, HCTZ, HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), SULFASALAZINE, ACETYLSALICYLIC ACID (ASPIRIN 81), FOLIC ACID and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced AGEUSIA (loss of taste), ANOSMIA (loss of smell), DECREASED APPETITE (loss of appetite), URINARY INCONTINENCE (loss control of bladder), ASTHENIA (extreme weakness), BLOOD GLUCOSE DECREASED (Blood sugar decreased), DIARRHOEA (Diarrhea), VOMITING (Vomiting), NAUSEA (Nausea) and FATIGUE (fatigue/ tiredness). On 16-Apr-2021, the patient experienced COVID-19 (COVID-19/ tested positive for Covid-19) (seriousness criterion hospitalization prolonged). The patient was treated with OXYGEN at a dose of 2 liter and DEXAMETHASONE at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19/ tested positive for Covid-19), AGEUSIA (loss of taste), ANOSMIA (loss of smell), DECREASED APPETITE (loss of appetite), URINARY INCONTINENCE (loss control of bladder), ASTHENIA (extreme weakness), BLOOD GLUCOSE DECREASED (Blood sugar decreased), DIARRHOEA (Diarrhea), VOMITING (Vomiting), NAUSEA (Nausea) and FATIGUE (fatigue/ tiredness) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Apr-2021, Blood glucose: unknown (Inconclusive) blood sugar levels tumble. On 16-Apr-2021, SARS-CoV-2 antibody test: unknown (Positive) Tested positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient is due for his second dose i.e on 19apr2021.  Company Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship is unlikely for the vaccine and likely due to the COVID-19 infection.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship is unlikely for the vaccine and likely due to the COVID-19 infection.
Patient called on 9/29/2020 to say she is still having pain on lying down,15 days after getting her flu-shot. She said the pain radiates from the injection site to above her elbow and towards the shoulder. Still has a little swelling at the injection site. She had not taken any over-the counter analgesia for the pain. She could move the arm on all directions. She was advised to take some otc analgesia, apply a cold compress to the swelling and Call her Primary care Physician. The next day, on follow up, she said she felt some relief by taking tylenol and applying a heating pad.
Flu like simptoms with fever, cough, sneezing for more than 1 week. I was taking Dayquil and Nyquil, Robatussin etc.
I noticed some minor muscular aches and upper respiratory issues bothering me the night prior from testing positive. I thought it was effects from my allergy pill. That next morning, I had some congestion and coughing. Flu-like symptoms were present. I had a clear positive on the antigen at home test. I developed a severe headache. I called my doctor immediately. I got Paxlovid that same day. I went through the 5 days of that medication. Within another day, I had substantial relief from the medication.
07/06/02 started with redness and swelling of left upper arm c/o pain c/o unable to sleep on 07/08/02. Seen in ER-told this was normal  mother states better by 07/09/02.
Diffuse red welts appeared two days after shots. Pustules - none; one or two papules rash appearing in face, hands, arms, feet, chin, stomach and back.
Within 5 minutes of injection the pt complained of strong dizziness and nausea and then within the hour a headache began. Symptoms have lasted 2 days thus far.
Fever of 101.5 for 36 hours, joint pain, extreme fatigue, loose stools
Rash on my thigh; This case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2022, the patient received the 1st dose of Shingrix. In January 2022, 2 days after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient developed rash on his/her thigh 2 days after a dose of Shingrix vaccine and that was in January and rash had still not gone away. The patient asked that what could he/she put on it that would help him/her. The follow-up could not be possible as no contact details were available.
Student is only 16yrs old and received Moderna instead of Pfizer. No symptoms to report.
Chills, aches, fatigue, low fever (100.1-100.7), headache, swollen gland right armpit. After 72 hours, lesser side effects, but still headache, fatigue, swollen gland.
After a few days, my daughter noticed ringing in one ear and then in the other. The noise seemed to vary in volume and intensity and by ear...sometimes in both but sometimes just in one. The sound seemed to get quieter as she approached her second vaccine, but when she got the second dose on May 21, the symptoms and reactions returned and intensified.
TIA immediately above right eye at four.  Inclusive of 4 pinpoint spots.  Severe short-term pain.  Loss of neighbors names was noticeable within 24 hours.  Names had to be re-learned from community directory.  Spoke at length with Dr. during exam preceding colonoscopy.  He identitified COVID shot as likely cause confirming my suspicion from in depth research of Covid shot adverse effects.
Fatigue and tingling lasted 2 days.  Diarrhea has been ongoing since 03/16/2021.  Have returned to the eating from the Autoimmune Paleo Diet plan with no success to date
Metallic taste,metallic taste gets worse on empty stomach; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste,metallic taste gets worse on empty stomach) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Metallic taste,metallic taste gets worse on empty stomach). At the time of the report, DYSGEUSIA (Metallic taste,metallic taste gets worse on empty stomach) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided by the reporter.
Severe hair loss. Headaches.  10/14/09 PC note servce dates 12/18/09 to 8/6/09. Patient's hair is falling out.